# AbbVie: what changed between 2025-11-08 and 2026-11-08 entity: /record/abbvie.md from: 2025-11-08 to: 2026-11-08 page: /record/abbvie/diff?from=2025-11-08&to=2026-11-08 json: /v1/entities/abbvie/diff?from=2025-11-08&to=2026-11-08 Between 2025-11-08 and 2026-11-08, AbbVie's record changed in 17 facts: 3 replaced (net income $4.28 billion → $4.23 billion; operating income $9.14 billion → $15.08 billion; revenue $56.33 billion → $61.16 billion), 7 added, 7 ended; 8 unchanged. State as of 2025-11-08: /record/abbvie.md?as_of=2025-11-08 · as of 2026-11-08: /record/abbvie.md?as_of=2026-11-08. Format: subject | predicate | value | valid range | confidence | status | claim. Posts and Hugging Face repos are left out (0 held on 2025-11-08, 0 on 2026-11-08). ## Replaced (3) The same fact with a different value: the claim that held on the earlier day, then the one that holds on the later day. - net income: $4.28 billion → $4.23 billion - [AbbVie](/record/abbvie.md) | net_income | 4,278,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_2A3E6A20A337](/claim/clm_2A3E6A20A337.md) | [clm_4595D4B200E2](/claim/clm_4595D4B200E2.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,226,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_2A3E6A20A337](/claim/clm_2A3E6A20A337.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - operating income: $9.14 billion → $15.08 billion - [AbbVie](/record/abbvie.md) | operating_income | 9,137,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_D4AF640165D7](/claim/clm_D4AF640165D7.md) | [clm_7198B453007F](/claim/clm_7198B453007F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 15,075,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_D4AF640165D7](/claim/clm_D4AF640165D7.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - revenue: $56.33 billion → $61.16 billion - [AbbVie](/record/abbvie.md) | revenue | 56,334,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_4A7BE8ED0078](/claim/clm_4A7BE8ED0078.md) | [clm_46C087CADCC6](/claim/clm_46C087CADCC6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | revenue | 61,160,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_4A7BE8ED0078](/claim/clm_4A7BE8ED0078.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm ## Added (7) Held on 2026-11-08, not on 2025-11-08. - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 10,774,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_A17F69D94691](/claim/clm_A17F69D94691.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 4,218,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_B8246C4E0E64](/claim/clm_B8246C4E0E64.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 6,267,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_5AF8A08D6F94](/claim/clm_5AF8A08D6F94.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 17,404,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_DA52AAE1BFB4](/claim/clm_DA52AAE1BFB4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,616,306 shares | valid 2026-10-26 to present | conf 0.95 | valid | [clm_54135339A00E](/claim/clm_54135339A00E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 147,680,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_0DE2793ECF77](/claim/clm_0DE2793ECF77.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -4,583,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_FA883B408C6E](/claim/clm_FA883B408C6E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm ## Ended (7) Held on 2025-11-08, not on 2026-11-08, and not replaced by another value. - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 5,629,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_F526599F9FFE](/claim/clm_F526599F9FFE.md) | [clm_E498EA77B417](/claim/clm_E498EA77B417.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 186,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_879DEDC1ACEA](/claim/clm_879DEDC1ACEA.md) | [clm_48C26099DBC0](/claim/clm_48C26099DBC0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,904,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_78F42A193166](/claim/clm_78F42A193166.md) | [clm_8A7602897846](/claim/clm_8A7602897846.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 15,776,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_2A1D46B6132E](/claim/clm_2A1D46B6132E.md) | [clm_7673BF825A9D](/claim/clm_7673BF825A9D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,384,632 shares | valid 2025-10-27 to 2026-02-10 | conf 0.95 | superseded | superseded_by [clm_F33386E6A71F](/claim/clm_F33386E6A71F.md) | [clm_A66CE3EA88E8](/claim/clm_A66CE3EA88E8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 133,898,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_BAF68C4E73F9](/claim/clm_BAF68C4E73F9.md) | [clm_9AD5C074902A](/claim/clm_9AD5C074902A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -2,642,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_6A970AB08DB3](/claim/clm_6A970AB08DB3.md) | [clm_E6BEEAB8A7CC](/claim/clm_E6BEEAB8A7CC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm ## Unchanged 8 claims held on both days: cik 1, fiscal_year_end 1, headquarters 1, listed_on 1, registrant_name 1, sic_industry 1, state_of_incorporation 1, ticker 1. ## Get this data - JSON: /v1/entities/abbvie/diff?from=2025-11-08&to=2026-11-08 - MCP: entity_diff(entity: "abbvie", from: "2025-11-08", to: "2026-11-08") - Entity twin: /record/abbvie.md · timeline: /timelines/abbvie.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.